Low Serum Angiogenin Concentrations in Patients With Type 2 Diabetes

This publication has 12 references indexed in Scilit:

• Reduced Expression of Vascular Endothelial Growth Factor Paralleled With the Increased Angiostatin Expression Resulting From the Upregulated Activities of Matrix Metalloproteinase-2 and -9 in Human Type 2 Diabetic Arterial Vasculature
  Circulation Research, 2006
• Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy
  Journal of Diabetes and its Complications, 2005
• Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2005
• Diagnosis and Classification of Diabetes Mellitus
  Diabetes Care, 2005
• Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone.
  International Journal of Molecular Medicine, 2004
• Decreased Cardiac Expression of Vascular Endothelial Growth Factor and Its Receptors in Insulin-Resistant and Diabetic States
  Circulation, 2002
• Therapeutic Angiogenesis Induced by Human Hepatocyte Growth Factor Gene in Rat Diabetic Hind Limb Ischemia Model
  Circulation, 2001
• Effect of Diabetes Mellitus on Formation of Coronary Collateral Vessels
  Circulation, 1999
• Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities.
  Proceedings of the National Academy of Sciences, 1994
• Lymphocyte-induced angiogenesis: a quantitative and sensitive assay of the graft-vs.-host reaction.
  Journal of Experimental Medicine, 1975